Harout Semerjian's Net Worth

-$28.3 Thousand

Estimate Recalculated Sep 8, 2024 07:38PM EST

Who is Harout Semerjian?

Harout Semerjian does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, and GLYCOMIMETICS INC.

SEC CIK

Harout Semerjian's CIK is 0001809747

Past Insider Trading and Trends

2020 was Harout Semerjian's most active year for acquiring shares with 2 total transactions. Harout Semerjian's most active month to acquire stocks was the month of December. 2022 saw Harout Semerjian paying a total of $32,250.00 for 448,500 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNOMEDICS INC No price found

President and CEO

Harout Semerjian owns 50,075 units of Common Stock, $0.01 par value per share. In the year 2020 Harout Semerjian filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
50.08K
—
—
50.08K
Apr 16
Form 3
—
0
—
—
0
No matching records found

GLYCOMIMETICS INC (GLYC) Snapshot price: $0.1596

Chief Executive Officer

Harout Semerjian owns 25,000 units of Common Stock which is worth $3,990.00. From 2021 to 2024 Harout Semerjian acquired a total of 25,000 shares in GLYCOMIMETICS INC at a cost of $32,250.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Jan 19
Form 4
∞
25K
$1.29
$32,250.00
25K
Nov 11
Form 4
—
0
—
—
0
Jan 21
Form 3
—
0
—
—
0
No matching records found